机器人辅助前列腺特异性膜抗原放射性引导手术用于初诊前列腺癌
本研究评估99mTc-PSMA机器人辅助放射性引导手术在初诊高危前列腺癌患者行机器人辅助根治性前列腺切除术中辅助检出淋巴结转移的安全性与可行性。共纳入12例患者,术中γ探头辅助切除PSMA高摄取(模板外)淋巴结及前列腺床残留病灶,体内灵敏度76%、特异度69%,体外诊断准确性更优,未发生高于Clavien-Dindo I级的并发症。
要点
- 99mTc-PSMA机器人辅助放射性引导手术在初诊前列腺癌中可行且安全。
- 术中γ探头检出11枚术前68Ga-PSMA PET/CT未发现的转移淋巴结。
- 体内灵敏度76%(95% CI,53%-92%)、特异度69%(95% CI,55%-81%)。
核心结论
- 机器人辅助99mTc-PSMA放射性引导手术在初诊设置中可行且安全,优化了RARP及扩大盆腔淋巴结清扫时淋巴结转移的检出。
- 进一步改进探测器技术可能优化机器人辅助99mTc-PSMA放射性引导手术的能力。
研究设计与样本
- 纳入初诊高危前列腺癌(≥cT3a、ISUP分级组≥3或PSA≥15 ng/mL)且潜在淋巴结转移(Briganti列线图风险>10%或术前影像提示)的男性患者。
- 患者行68Ga-PSMA PET/CT分期,术前给予99mTc标记PSMA配体(99mTc PSMA I&S;500 MBq)后行SPECT/CT。
- 行机器人辅助根治性前列腺切除术包括扩大盆腔淋巴结清扫,术中使用原型DROP-IN γ探头追踪PSMA高摄取组织,并离体测量切除标本。
- 共纳入12例患者(中位年龄68岁,前列腺特异性抗原9.15 ng/mL)。
主要发现
- 大多数患者为ISUP 5前列腺癌(75%),术前PSMA PET显示淋巴结高摄取者占64%。
- DROP-IN探头辅助切除了PSMA高摄取(模板外)淋巴结及前列腺床残留病灶。
- 探头识别出11枚术前68Ga-PSMA PET/CT未观察到的转移淋巴结。
- 切除的74份前列腺外组织标本中,22份(29.7%)含前列腺癌。
- 体内漏诊淋巴结(n=5)和体外漏诊淋巴结(n=5)中,90%为微转移(≤3 mm)。
关键数值与推荐
- 体内放射性计数≥背景参考的1.5倍视为阳性,体外绝对计数≥10视为阳性。
- 体内γ探头灵敏度76%(95% CI,53%-92%)、特异度69%(95% CI,55%-81%)、阳性预测值50%、阴性预测值88%。
- 体外灵敏度76%(95% CI,53%-92%)、特异度96%(95% CI,87%-99%)、阳性预测值89%、阴性预测值91%。
- 未发生高于Clavien-Dindo I级的并发症。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The objective of this study was to evaluate the safety and feasibility of 99mTc-based prostate-specific membrane antigen (PSMA) robot-assisted-radioguided surgery to aid or improve the intraoperative detection of lymph node metastases during primary robot-assisted radical prostatectomy (RARP) for prostate cancer (PCa). Methods: Men with primary high-risk PCa (≥ cT3a, International Society of Urological Pathology (ISUP) grade group ≥ 3 or prostate-specific antigen of ≥ 15 ng/mL) with potential lymph node metastasis (Briganti nomogram risk > 10% or on preoperative imaging) were enrolled in the study. Patients underwent staging 68Ga-PSMA PET/CT scanning. Preoperatively, a 99mTc-labeled PSMA ligand (99mTc PSMA I&S; 500 MBq) was administered followed by SPECT/CT. A RARP including extended pelvic lymph node dissection was performed, with intraoperative tracing of PSMA-avid tissues using a prototype DROP-IN γ-probe. Resected specimens were also measured ex vivo. Histopathologic concordance with probe findings was evaluated. A radiotracer count of ≥ 1.5 times the background reference (in vivo), and ≥ 10 (absolute count) in the ex vivo setting, was considered positive. Results: Twelve patients were included (median age, 68 y, and prostate-specific antigen, 9.15 ng/mL). Most of the patients harbored ISUP 5 PCa (75%) and had avid lymph nodes on preoperative PSMA PET (64%). The DROP-IN probe aided resection of PSMA-avid (out-of-template) lymph nodes and residual disease at the prostate bed. Eleven metastatic lymph nodes were identified by the probe that were not observed on preoperative 68Ga-PSMA PET/CT. Of the 74 extraprostatic tissue specimens that were resected, 22 (29.7%) contained PCa. The sensitivity, specificity, positive predictive value, and negative predictive value of inpatient use of the γ-probe were 76% (95% CI, 53%-92%), 69% (95% CI, 55%-81%), 50%, and 88%, respectively. Ex vivo, the diagnostic accuracy was superior: 76% (95% CI, 53%-92%), 96% (95% CI, 87%-99%), 89%, and 91%, respectively, for sensitivity, specificity, positive predictive value, and negative predictive value. Of the missed lymph nodes in vivo (n = 5) and ex vivo (n = 5), 90% were micrometastasis (≤3 mm). No complications greater than Clavien-Dindo Grade I occurred. Conclusion: Robot-assisted 99mTc-based PSMA-radioguided surgery is feasible and safe in the primary setting, optimizing the detection of nodal metastases at the time of RARP and extended pelvic lymph node dissection. Further improvement of the detector technology may optimize the capabilities of robot-assisted 99mTc-based PSMA-radioguided surgery.
引用
- Gondoputro W, Scheltema MJ, Blazevski A, et al. Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate Cancer. J Nucl Med. 2022. PMID: 35241483. doi:10.2967/jnumed.121.263743
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。